Neoprospecta

About:

Neoprospecta uses high-throughput genomic sequencing and large scale bioinformatics.

Top Investors: CVENTURES

Description:

Neoprospecta, a contract research company, uses high-throughput genomic sequencing and large scale bioinformatics to find new genes, enzymes, and other proteins from the biodiversity. It specializes in bioprospecting of new enzymes, peptides, and other proteins. Neoprospecta offers custom metagenomic bioprospection, contract research, enzyme development, and conservation biology services. Luiz Fernando Valter de Oliveira, Luiz Felipe Valter de Oliveira, Ronaldo Mota, and Marcos Carvalho founded it on January 21, 2011, with its headquarters in Florianópolis in Brazil.

Total Funding Amount:

4.5M BRL

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Florianópolis, Santa Catarina, Brazil

Founded Date:

2011-01-21

Contact Email:

felipe(AT)neoprospecta.com

Founders:

Luiz Felipe de Oliveira, Luiz Oliveira, Marcos Carvalho, Ronaldo Mota

Number of Employees:

11-50

Last Funding Date:

2014-08-18

IPO Status:

Private

Industries: